Volume 6 Issue 9, Sep 2021

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 6 Issue 9, Sep 2021:
Letter
SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses
Yuanmei Zhu,Danwei Yu,Yue Hu,Tong Wu,Huihui Chong &…Yuxian He  ORCID: orcid.org/0000-0003-2048-6696